Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.
暂无分享,去创建一个
M. Eriksson | S. Widell | S Widell | M Eriksson | R Hast | I Arvidsson | P Bemell | R. Hast | I. Arvidsson | P. Bemell
[1] G. Verhoef. Clinicomorphological features of myelodysplastic syndromes , 1994 .
[2] D. Bowen. What is ineffective erythropoiesis in myelodysplastic syndromes? , 1995, Leukemia & lymphoma.
[3] J. Bennett,et al. Classification and morphologic features of the myelodysplastic syndromes. , 1992, Seminars in oncology.
[4] H. Preisler,et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. , 1995, Blood.
[5] E. Wattel,et al. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. , 1995, Leukemia.
[6] G. Tricot,et al. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations , 1985, British journal of haematology.
[7] Y. Kagami,et al. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. , 1994, Leukemia.
[8] A. Öst,et al. Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes , 1995, American journal of hematology.
[9] H. Gralnick,et al. Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.
[10] L. Kanter‐Lewensohn,et al. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. , 1997, Leukemia research.
[11] C. Preudhomme,et al. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes , 1995, British journal of haematology.
[12] S. Widell,et al. Balloon-like platelets in myelodysplastic syndromes--a feature of dysmegakaryopoiesis? , 1987, Leukemia research.
[13] G. Mufti,et al. The myelodysplastic syndromes. , 1987, Springer Berlin Heidelberg.
[14] S. Widell,et al. Dysplastic peripheral blood polymorphs link acute myeloblastic leukaemia in elderly to the mvelodvsdastic Syndromes , 1992, European journal of haematology.
[15] M. Ichihara,et al. Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. , 1994, Blood.
[16] H. Heimpel,et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. , 1989, Blood.
[17] F. Mitelman. ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics , 1992 .
[18] A. Nordgren,et al. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. , 1996, Leukemia.
[19] A. Öst,et al. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. , 1989, Leukemia research.
[20] J. Rowley,et al. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes , 1986 .
[21] R. Hast,et al. Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[22] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[23] B. Vogelstein,et al. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.